B
AGN.PRA

Barings’s Allergan plc AGN.PRA Stock Holding History

Barings’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Hold
0
– – – 141
2017
Q3 		– Sell
-14,500
Closed -$12.5M – 907
2017
Q2 		$12.5M Hold
14,500
– – 0.36% 60
2017
Q1 		$12.3M Hold
14,500
– – 0.25% 51
2016
Q4 		$11M Hold
14,500
– – 0.28% 34
2016
Q3 		$11.9M Hold
14,500
– – 0.31% 28
2016
Q2 		$12.1M Hold
14,500
– – 0.31% 34
2016
Q1 		$13.3M Buy
+14,500
New +$13.9M 0.35% 28
2015
Q4 		– Sell
-14,500
Closed -$13.6M – 972
2015
Q3 		$13.6M Buy
+14,500
New +$15.1M 0.34% 35

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Barings's AGN.PRA Position: Q4 2017 in Review

Barings held its Allergan plc (AGN.PRA) position steady in Q4 2017 at 0 shares worth $8.47M. The position accounts for 0.11% of the portfolio, ranked #141.

Barings first reported a position in AGN.PRA in Q3 2015 and has held it in 7 quarters since. The position peaked at $13.6M in Q3 2015. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Barings held 0 shares of Allergan plc worth $8.47M as of Q4 2017.
  • Barings left its Allergan plc share count unchanged in Q4 2017.
  • Allergan plc made up 0.11% of Barings's portfolio in Q4 2017, its #141 holding.
  • Barings first reported a position in Allergan plc in Q3 2015 and has held it in 7 quarters since.
  • Barings's Allergan plc position peaked at $13.6M in Q3 2015.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Barings's 13F filing for Q4 2017, filed 8 Feb 2018.